Therapeutic Respiratory Devices

Therapeutic Respiratory Devices Market Outlook

The global Therapeutic Respiratory Devices market is projected to reach approximately USD 30 billion by 2035, growing at a CAGR of around 8.5% from 2025 to 2035. This market growth can largely be attributed to the increasing prevalence of respiratory diseases, an aging population, and the rising awareness of respiratory health. Furthermore, technological advancements in respiratory devices and an expanding patient population requiring long-term respiratory support have significantly bolstered the market. The recent global health crises have accelerated demand for effective therapeutic solutions, leading to substantial investments in research and development of respiratory devices. This phenomenon is expected to continue, as healthcare providers seek innovative solutions to improve patient outcomes and quality of life.

Growth Factor of the Market

The growth of the Therapeutic Respiratory Devices market is fueled by several key factors. Firstly, the increasing rate of respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and respiratory infections necessitates the demand for effective monitoring and therapeutic devices. Additionally, the rising geriatric population, particularly in developed regions, is more susceptible to respiratory conditions, which in turn is a significant driver for the market. Secondly, advancements in technology are enabling the development of more efficient and user-friendly devices, making them more accessible to patients in homecare settings. Furthermore, a growing trend towards home healthcare solutions is giving rise to the adoption of portable and easy-to-use respiratory devices, thus expanding their market reach. Increased expenditure on healthcare and favorable reimbursement policies for respiratory therapies are also contributing to the market’s expansion.

Key Highlights of the Market

• The market is expected to grow significantly due to the increasing prevalence of chronic respiratory diseases.
• Technological advancements are leading to the development of innovative therapeutic devices.
• Homecare settings are becoming increasingly popular for respiratory treatment, offering convenience and comfort to patients.
• North America holds a substantial share of the market, driven by high healthcare expenditure and advanced infrastructure.
• The demand for portable respiratory devices is expected to surge due to the growing trend of telehealth and remote patient monitoring.

By Product Type

Positive Airway Pressure Devices:

Positive Airway Pressure (PAP) devices are primarily used to treat obstructive sleep apnea by delivering a continuous flow of air to keep the airways open during sleep. The rising incidence of sleep apnea, particularly among the aging population, is a significant factor driving the demand for these devices. PAP devices come in various forms, including Continuous Positive Airway Pressure (CPAP) and Bi-Level Positive Airway Pressure (BiPAP) units. They not only enhance patient comfort and compliance but also contribute to a reduction in associated health complications. The increased focus on preventive healthcare and the growing awareness of sleep disorders are expected to further boost the market for PAP devices in the coming years.

Nebulizers:

Nebulizers are used to deliver medication directly into the lungs in the form of mist, allowing for immediate relief from respiratory conditions such as asthma and COPD. The rising prevalence of these diseases, coupled with a need for effective drug delivery systems, is propelling the nebulizer segment of the market. Additionally, advancements in nebulizer technology, including portable and battery-operated models, are making these devices more accessible and user-friendly. The growing inclination towards self-administration of medication at home is also a key factor that is expected to fuel the demand for nebulizers in the foreseeable future.

Oxygen Concentrators:

Oxygen concentrators are essential devices for patients who require supplemental oxygen due to respiratory conditions, heart issues, or other health concerns. The increasing prevalence of chronic respiratory diseases like COPD necessitates the use of oxygen therapy, thereby driving the oxygen concentrator market. Additionally, advancements in technology have led to the development of portable oxygen concentrators, enabling patients to maintain mobility and independence while receiving therapeutic oxygen. The trend towards home healthcare and increased patient comfort is also boosting the demand for these devices, as they provide a viable solution for long-term respiratory support.

Ventilators:

Ventilators play a critical role in providing respiratory support to patients with severe respiratory distress and are increasingly being used in both hospital and home settings. The surge in respiratory conditions, coupled with the recent global health crises, has led to an unprecedented demand for ventilators. Technological advancements are improving the functionality and efficiency of ventilators, enabling better patient outcomes. Moreover, the shift towards homecare for chronic respiratory patients is expected to drive the adoption of portable and compact ventilators, further expanding this segment of the market.

Humidifiers:

Humidifiers are essential devices that add moisture to the air, alleviating symptoms associated with dry respiratory conditions. They are often used in conjunction with other therapeutic respiratory devices to enhance comfort and effectiveness. The increasing awareness about respiratory health and the benefits of maintaining optimal humidity levels in treating conditions like asthma and bronchitis are driving the market for humidifiers. Additionally, innovations in humidifier technology, such as ultrasonic and steam-based humidifiers, are making these devices more efficient and user-friendly, attracting a broader consumer base.

By Application

Chronic Obstructive Pulmonary Disease:

Chronic Obstructive Pulmonary Disease (COPD) is a major application for therapeutic respiratory devices, as it encompasses a wide range of conditions that affect airflow in the lungs, including emphysema and chronic bronchitis. The increasing prevalence of COPD, driven by factors such as smoking, air pollution, and genetic predisposition, necessitates effective management and treatment solutions. Devices such as nebulizers and oxygen concentrators are commonly used in the management of COPD, helping patients maintain better respiratory function and quality of life. The rising awareness of the condition and the importance of early diagnosis and treatment are expected to further enhance the demand for respiratory devices in this segment.

Asthma:

Asthma is another significant application area for therapeutic respiratory devices, particularly in the pediatric population. The increasing incidence of asthma and the need for effective management strategies are driving the demand for devices like inhalers and nebulizers. With the growing understanding of asthma triggers and the importance of maintaining control over the condition, healthcare providers are emphasizing the use of therapeutic devices for effective treatment. Additionally, advancements in inhaler technology, such as smart inhalers equipped with digital tracking, are enhancing patient compliance and ensuring better management of asthma symptoms.

Sleep Apnea:

Sleep apnea is a prevalent condition that affects millions worldwide, and therapeutic respiratory devices, particularly PAP devices, play a crucial role in its management. The rising awareness of sleep disorders and their associated health risks is driving the demand for effective treatment options. As more individuals seek diagnosis and treatment for sleep apnea, healthcare providers are increasingly recommending the use of PAP devices, significantly contributing to market growth. The emphasis on patient comfort and improving sleep quality is further boosting the demand for innovative and user-friendly devices in this application segment.

Respiratory Distress Syndrome:

Respiratory Distress Syndrome, particularly in premature infants, requires immediate and effective respiratory support. Ventilators and other therapeutic devices are essential in managing this critical condition. The rising incidence of preterm births and advancements in neonatal care are driving the demand for specialized respiratory devices. As hospitals and healthcare facilities invest in improving neonatal care, the market for therapeutic devices used in managing respiratory distress syndrome is expected to expand significantly, focusing on enhancing patient outcomes and reducing complications.

Cystic Fibrosis:

Cystic fibrosis is a genetic disorder that significantly affects lung function, requiring ongoing respiratory therapy. The increasing prevalence of cystic fibrosis and the need for effective management strategies are driving the demand for therapeutic devices such as nebulizers and airway clearance devices. Ongoing research and advancements in treatment options are also contributing to the growth of this application segment. With an emphasis on improving the quality of life for patients with cystic fibrosis, the demand for effective and efficient respiratory devices is expected to rise in the coming years.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics are the primary distribution channel for therapeutic respiratory devices, as they provide critical care and treatment for patients with severe respiratory conditions. The rising number of hospital admissions due to respiratory illnesses fuels the demand for these devices in clinical settings. Additionally, healthcare providers are increasingly adopting advanced technologies and innovative devices to improve patient outcomes. The integration of respiratory care in hospital protocols and the emphasis on patient-centered care are further driving the demand for therapeutic respiratory devices within this distribution channel.

Homecare Settings:

The trend towards home healthcare is significantly transforming the distribution of therapeutic respiratory devices. Patients prefer receiving treatment in the comfort of their homes, which is leading to a growing demand for portable and user-friendly devices. Homecare providers are increasingly adopting therapeutic respiratory devices to cater to patients with chronic conditions, promoting independence and improving quality of life. The convenience of remote monitoring and telehealth services is enhancing the appeal of homecare solutions, resulting in a marked increase in the distribution of respiratory devices in homecare settings.

Retail Pharmacies:

Retail pharmacies serve as an essential distribution channel for therapeutic respiratory devices, particularly for over-the-counter products such as inhalers and nebulizers. The convenience of accessing respiratory devices through retail pharmacies is driving the demand for these products. As pharmacies expand their range of healthcare offerings, the availability of respiratory devices in retail settings is expected to increase. Moreover, the trend towards self-medication and the growing awareness of respiratory health among consumers are enhancing the role of retail pharmacies as a key distribution channel for therapeutic respiratory devices.

By Technology

Electrostatic Filtration:

Electrostatic filtration technology is increasingly being utilized in therapeutic respiratory devices to enhance air quality and ensure effective filtration of airborne particles. This technology works by using charged particles to attract and capture pollutants, viruses, and allergens from the air. The rising awareness regarding indoor air quality and its impact on respiratory health is driving the demand for devices equipped with electrostatic filters. As consumers prioritize health and safety, the adoption of electrostatic filtration technology in respiratory devices is expected to witness significant growth, contributing to an overall improvement in respiratory health outcomes.

HEPA Filter:

HEPA (High Efficiency Particulate Air) filters are widely recognized for their effectiveness in capturing fine particles, making them a popular choice in therapeutic respiratory devices. The increasing prevalence of allergies and respiratory diseases is driving the demand for devices equipped with HEPA filters, as they provide an added layer of protection against harmful airborne particles. Moreover, regulatory standards and guidelines promoting the use of HEPA filtration in healthcare settings are further enhancing the adoption of this technology in respiratory devices. The growing concern over air quality and its impact on health ensures that HEPA filters will remain a critical component in the design and functionality of therapeutic respiratory devices.

Activated Carbon:

Activated carbon technology is employed in therapeutic respiratory devices to adsorb harmful gases and odors, thereby enhancing air quality. This technology is particularly effective in filtering volatile organic compounds (VOCs) and other pollutants, making it essential for individuals with respiratory sensitivities. The increasing awareness of indoor air pollution and its adverse effects on respiratory health is driving the demand for devices that utilize activated carbon filters. As consumers prioritize health and well-being, the adoption of activated carbon technology in respiratory devices is expected to rise, ensuring cleaner and safer air for users.

UV-C Light:

UV-C light technology is gaining traction in therapeutic respiratory devices for its ability to disinfect and sterilize air and surfaces. This technology utilizes ultraviolet light to kill or inactivate microorganisms, providing an additional layer of protection against airborne pathogens. The recent global health concerns have heightened the awareness of infection control, driving the demand for devices equipped with UV-C light technology. As healthcare providers and consumers prioritize hygiene and safety, the use of UV-C light in respiratory devices is expected to expand significantly, contributing to improved respiratory health outcomes.

Ionic Filtration:

Ionic filtration technology uses charged ions to trap and eliminate airborne pollutants, making it an effective solution for improving air quality. This technology is particularly beneficial for individuals suffering from allergies and respiratory conditions, as it reduces the presence of allergens and irritants in the environment. The growing concern over air quality and its impact on health is driving the demand for therapeutic respiratory devices with ionic filtration technology. As consumers become more health-conscious, the adoption of ionic filtration solutions in respiratory devices is anticipated to witness significant growth, enhancing overall respiratory health.

By Region

The North American region holds a substantial share of the Therapeutic Respiratory Devices market, accounting for approximately 40% of the total market revenue in 2025. The dominance of this region is attributed to the high prevalence of respiratory diseases, significant healthcare expenditure, and the presence of advanced healthcare infrastructure. Technological advancements and a well-established reimbursement framework further facilitate the growth of the therapeutic respiratory devices market in North America. The CAGR for this region is expected to be around 9% during the forecast period, driven by the increasing demand for innovative respiratory solutions and the aging population.

In Europe, the Therapeutic Respiratory Devices market is also witnessing steady growth, accounting for approximately 30% of the global market share. The increasing focus on respiratory health, coupled with supportive government initiatives and advanced healthcare systems, is driving the demand for therapeutic devices in this region. Additionally, the rising prevalence of chronic respiratory diseases and the growing awareness of preventive healthcare are contributing to market expansion. The Asia Pacific region is expected to exhibit the highest CAGR of around 10% during the forecast period, propelled by rapid urbanization, an increasing geriatric population, and rising pollution levels, all of which are leading to a surge in respiratory diseases.

Opportunities

The Therapeutic Respiratory Devices market is poised for significant opportunities driven by the increasing prevalence of respiratory disorders. As the global population ages and the incidence of chronic diseases rises, there will be a rising demand for advanced respiratory solutions. This trend is particularly evident in developing regions, where increasing healthcare access and improved economic conditions are leading to a greater focus on healthcare spending. Additionally, innovations in telehealth and remote monitoring technologies present a unique opportunity for the market, allowing for enhanced patient management and treatment adherence. Companies that can leverage these technological advancements to provide effective solutions for respiratory conditions will likely gain a competitive edge in the market.

Moreover, the ongoing research and development initiatives aimed at creating next-generation therapeutic respiratory devices present further opportunities. Manufacturers that invest in developing devices equipped with smart technology, such as connectivity features and integrated monitoring systems, will be well-positioned to meet the evolving needs of patients and healthcare providers. Additionally, partnerships and collaborations between device manufacturers, healthcare providers, and research institutions can facilitate the development of innovative solutions, enhancing patient outcomes and shaping the future of respiratory care. As the healthcare landscape evolves, the demand for comprehensive respiratory management solutions will continue to rise, creating vast opportunities for growth in this market.

Threats

While the Therapeutic Respiratory Devices market presents substantial growth potential, there are notable threats that could impede its progress. Regulatory challenges and stringent compliance requirements can pose significant hurdles for manufacturers, particularly for those venturing into new markets or launching innovative devices. Navigating the complex regulatory landscape can be time-consuming and costly, which may deter smaller companies from entering the market. Additionally, rapid technological advancements can render existing devices obsolete, forcing manufacturers to continuously innovate and invest in research and development to stay competitive. This constant pressure to evolve can strain resources, particularly for smaller companies with limited budgets.

Furthermore, the market is susceptible to economic fluctuations, which can impact healthcare spending and investment in new technologies. In times of economic downturn, healthcare budgets may be restricted, leading to reduced expenditure on therapeutic respiratory devices. Additionally, competition from alternative therapies and natural remedies can also pose a threat to the market, as patients may opt for these solutions over conventional devices. The presence of counterfeit devices and substandard products can undermine consumer trust and adversely affect market growth. Addressing these threats will require strategic planning, innovation, and effective market positioning by industry players.

Competitor Outlook

• Philips Healthcare
• ResMed Inc.
• Medtronic plc
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Smiths Medical
• Invacare Corporation
• Drive DeVilbiss Healthcare
• Omron Healthcare, Inc.
• Boehringer Ingelheim
• Honeywell International Inc.
• 3M Company
• CareFusion Corporation
• Nidek Co., Ltd.
• Vyaire Medical, Inc.

The competitive landscape of the Therapeutic Respiratory Devices market is characterized by the presence of several key players, each striving to gain market share through innovation, strategic partnerships, and comprehensive product offerings. Major companies such as Philips Healthcare and ResMed Inc. dominate the market, leveraging their strong brand recognition and established distribution networks. These companies are actively investing in research and development to enhance their product portfolios and introduce advanced therapeutic solutions aimed at improving patient outcomes. Additionally, collaboration with healthcare providers and regulatory bodies is crucial to ensure compliance and facilitate the introduction of new technologies in the market.

Medtronic plc and Fisher & Paykel Healthcare Limited are also notable players within this market. Medtronic leverages its extensive resources and technology capabilities to advance its respiratory device offerings, focusing on integrated solutions for chronic respiratory conditions. Fisher & Paykel, known for its innovative humidification and respiratory support systems, continues to expand its market presence through targeted marketing and product development. Additionally, companies such as Invacare Corporation and Drive DeVilbiss Healthcare are focusing on the homecare segment, offering portable and user-friendly devices that cater to the growing demand for home-based respiratory therapies.

The presence of emerging players and new entrants in the Therapeutic Respiratory Devices market further intensifies competition. Companies such as Omron Healthcare, Inc. and Nidek Co., Ltd. are gaining traction by introducing technologically advanced devices that cater to specific patient needs. These companies often prioritize affordability and accessibility, making their products appealing to a broader consumer base. Furthermore, the increasing trend towards telehealth and remote monitoring solutions has encouraged many companies to innovate and adapt their product offerings to align with changing healthcare delivery models. Overall, the competitive landscape of the Therapeutic Respiratory Devices market is dynamic, driven by innovation and evolving patient needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 ResMed Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Nidek Co., Ltd.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Philips Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Boehringer Ingelheim
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Invacare Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vyaire Medical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 CareFusion Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Omron Healthcare, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Drive DeVilbiss Healthcare
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Honeywell International Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fisher & Paykel Healthcare Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Therapeutic Respiratory Devices Market, By Technology
    • 6.1.1 Electrostatic Filtration
    • 6.1.2 HEPA Filter
    • 6.1.3 Activated Carbon
    • 6.1.4 UV-C Light
    • 6.1.5 Ionic Filtration
  • 6.2 Therapeutic Respiratory Devices Market, By Application
    • 6.2.1 Chronic Obstructive Pulmonary Disease
    • 6.2.2 Asthma
    • 6.2.3 Sleep Apnea
    • 6.2.4 Respiratory Distress Syndrome
    • 6.2.5 Cystic Fibrosis
  • 6.3 Therapeutic Respiratory Devices Market, By Product Type
    • 6.3.1 Positive Airway Pressure Devices
    • 6.3.2 Nebulizers
    • 6.3.3 Oxygen Concentrators
    • 6.3.4 Ventilators
    • 6.3.5 Humidifiers
  • 6.4 Therapeutic Respiratory Devices Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Homecare Settings
    • 6.4.3 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Therapeutic Respiratory Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Therapeutic Respiratory Devices market is categorized based on

By Product Type

• Positive Airway Pressure Devices
• Nebulizers
• Oxygen Concentrators
• Ventilators
• Humidifiers

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis

By Distribution Channel

• Hospitals & Clinics
• Homecare Settings
• Retail Pharmacies

By Technology

• Electrostatic Filtration
• HEPA Filter
• Activated Carbon
• UV-C Light
• Ionic Filtration

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Healthcare
• ResMed Inc.
• Medtronic plc
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Smiths Medical
• Invacare Corporation
• Drive DeVilbiss Healthcare
• Omron Healthcare, Inc.
• Boehringer Ingelheim
• Honeywell International Inc.
• 3M Company
• CareFusion Corporation
• Nidek Co., Ltd.
• Vyaire Medical, Inc.